Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms

Advances in Experimental Medicine and Biology

Volumn 583, Issue , 2006, Pages 481-492

  Marcinkiewicz, Janusz ^a   Kurnyta, Maria ^a   Biedroń, Rafa ^a   Bobek, Małgorzata ^a   Kontny, Ewa ^b   Maśliński, Włodzimierz ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934436267     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33504-9_54     Document Type: Conference Paper

References (33)

1. Abraham, N. G., Lin, J. H., Schwartzman, M. L., Levere, R.D., and Shibahara, S., 1988, The physiological significance of heme oxygenase, Int. J. Biochem. 20:543.
2. Baker, D. M., Jones, J. A., Nguyen-Van-Tam, J. S., Lloyd, J. H., Morris, D. L., Bourke, J. B., Steele, R. J., and Hardcastle, J. D., 1994, Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery, Br. J. Surg. 8:1054.
3. Barua, M., Liu, Y., and Quinn, M. R., 2001, Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity, J. Immunol. 167:2275.
4. Bedrosian, I., Sofia, R. D., Wolff, S. M., and Dinarello, C. A., 1991, Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells, Cytokine 3:568.
5. Browne, M. K., Leslie, G. B., and Pfirrmann, R. W., 1976, Taurolin, a new chemotherapeutic agent, J. Appl. Bacteriol. 41:363.
6. Darnowski, J. W., Goulette, F. A., Cousens, L. P., Chatterjee, D., and Calabresi, P., 2004, Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer, Cancer Chemother. Pharmacol. 54:249.
7. Gorman, S. P., McCafferty, D. F., Woolfson, A. D., and Jones, D. S., 1987, Reduced adherence of microorganisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent, J. Appl. Bacteriol. 62:315.
8. Kanayama, A., Inoue, J., Sugita-Konishi, Y., Shimizu, M., and Miyamoto, Y., 2002, Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation, J. Biol. Chem. 277:24049.
9. Kirsch, L. E. and Sihn, Y. S., 1997, The effect of polyvinylpyrrolidine on the stability of taurolidine, Pharm. Dev. Technol. 2:345.
10. Klebanoff, S. J. and Hamon, C. B., 1992, Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes, J. Reticuloendothel. Soc. 12:170.
11. Kontny, E., Szczepanska, K., Kowalczewski, J., Kurowska, M., Janicka, I., Marcinkiewicz, J., and Maslinski, W., 2000, The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes, Arthritis Rheum. 43:2169.
12. Kushida, T., Li Volti, G., Quan, S., Goodman, A., and Abraham, N. G., 2002, Role of human heme oxygenase-1 in attenuating TNF-alpha-mediated inflammation injury in endothelial cells, J. Cell Biochem.87:377.
13. Learn, D. B., Fried, V. A., and Thomas, E. L., 1990, Taurine and hypotaurine content of human leukocytes, J. Leukoc. Biol. 48:174.
14. Lee, T. S. and Chau, L. Y., 2002, Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice, Nat. Med. 8:240.
15. Marcinkiewicz, J., Grabowska, A., Bereta, J., and Stelmaszynska, T., 1995, Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators, J Leukoc Biol. 58:667.
16. Marcinkiewicz, J., Mak, M., Bobek, M., Biedron, R., Bialecka, A., Koprowski, M., Kontny, E., and Maslinski, W., 2005, Is there a role of taurine bromamine in inflammation? Interactive effects with nitrite and hydrogen peroxide, Inflamm. Res. 54:42.
17. Marcinkiewicz, J., Nowak, B., Grabowska, A., Bobek, M, Petrovska, L., and Chain, B., 1999, Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system, Immunology 98:371.
18. Marcinkiewicz, J., 1997, Neutrophil chloramines: missing links between innate and acquired immunity, Immunol. Today 18:677.
19. McCourt, M., Wang, J. H., Sookhai, S., and Redmond, H. P., 2000, Taurolidine inhibits tumor cell growth in vitro and in vivo, Ann. Surg. Oncol. 7:685.
20. Myers, E. and Allwood, M. C., 1980, The interaction between taurolin and endotoxin, Microbios Lett. 13:141.
21. Nagl, M., Hess, M. W., Pfaller, K., Hengster, P., and Gottardi, W., 2000, Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system, Antimicrob. Agents Chemother. 44:2507.
22. Nici, L., Monfils, B., and Calabresi, P., 2004, The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma, Clin. Cancer Res. 10:7655.
23. Olszanecki, R. and Marcinkiewicz, J., 2004, Taurine chloramine and taurine bromamine induce heme oxygenase-1 in resting and LPS-stimulated J774.2 macrophages, Amino Acids 27:29.
24. Park, E., Schuller-Lewis, G., and Quinn, M. R., 1995, Taurine chloramine inhibits production of nitric oxide and the TNF- α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events, J. Immunol. 154:4778.
25. Schuller-Levis, G. B. and Park, E., 2003, Taurine: new implications for an old amino acid, FEMS Microbiol.Lett. 226:195.
26. Staubach, K. H., 1997, Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation, Langenbecks Arch. Chir. 382:S26.
27. Thomas, E. L., Bozeman, P. M., Jefferson, M. M., and King, C. C., 1995, Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. Formation of bromamines, J. Biol. Chem. 270:2906.
28. Thomas, E. L., Grisham, M. B., and Jefferson, M. M., 1986, Preparation and characterization of chloramines, Methods Enzymol. 132:569.
29. Torres-Viera, C., Thauvin-Eliopoulos, C., Souli, M., DeGirolam, P., Farris, M. G., Wennersten, C. B., Sofia, R.D., and Eliopoulos, G. M., 2000, Activities of taurolidine in vitro and in experimental enterococcal endocarditis, Antimicrob Agents Chemother. 44:1720.
30. Traub, W. H., Leonhard, B., and Bauer, D., 1993, Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae, Chemotherapy 39:322 .
31. Vicente, A. M., Guillen, M. I., Habib, A., and Alcaraz, M. J., 2003, Beneficial effects of heme oxygenase-1 upregulation in the development of experimental inflammation induced by zymosan, J. Pharmacol. Exp. Ther. 307:1030
32. Watson, R. W, Redmond, H. P., McCarthy, J., and Bouchier-Hayes, D., 1995, Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine, J. Leukoc. Biol. 58:299.
33. Willatts, S. M., Radford, S., and Leitermann, M., 1995, Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial, Crit. Care Med. 23:1033.